- Home
- OCCI vs SEER Comparison
OCCI vs SEER Comparison
Compare OCCI & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCCI
- SEER
- Stock Information
- Founded
- OCCI N/A
- SEER 2017
- Country
- OCCI United States
- SEER United States
- Employees
- OCCI N/A
- SEER N/A
- Industry
- OCCI Trusts Except Educational Religious and Charitable
- SEER Medicinal Chemicals and Botanical Products
- Sector
- OCCI Finance
- SEER Health Care
- Exchange
- OCCI Nasdaq
- SEER Nasdaq
- Market Cap
- OCCI 146.7M
- SEER 129.7M
- IPO Year
- OCCI N/A
- SEER 2020
- Fundamental
- Price
- OCCI $7.11
- SEER $2.31
- Analyst Decision
- OCCI
- SEER Hold
- Analyst Count
- OCCI 0
- SEER 1
- Target Price
- OCCI N/A
- SEER $3.00
- AVG Volume (30 Days)
- OCCI 115.8K
- SEER 217.4K
- Earning Date
- OCCI 12-11-2023
- SEER 02-27-2025
- Dividend Yield
- OCCI 24.32%
- SEER N/A
- EPS Growth
- OCCI N/A
- SEER N/A
- EPS
- OCCI N/A
- SEER N/A
- Revenue
- OCCI N/A
- SEER $14,608,000.00
- Revenue This Year
- OCCI N/A
- SEER N/A
- Revenue Next Year
- OCCI $10.19
- SEER $34.78
- P/E Ratio
- OCCI N/A
- SEER N/A
- Revenue Growth
- OCCI N/A
- SEER N/A
- 52 Week Low
- OCCI $5.47
- SEER $1.51
- 52 Week High
- OCCI $10.15
- SEER $2.63
- Technical
- Relative Strength Index (RSI)
- OCCI 41.99
- SEER 48.93
- Support Level
- OCCI $7.04
- SEER $2.15
- Resistance Level
- OCCI $7.16
- SEER $2.37
- Average True Range (ATR)
- OCCI 0.11
- SEER 0.11
- MACD
- OCCI -0.04
- SEER -0.03
- Stochastic Oscillator
- OCCI 17.54
- SEER 37.08
About OCCI OFS Credit Company Inc.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.